Financial Data and Key Metrics Changes - Total revenues before reimbursements for Q3 2025 were $72.2 million, a decrease of 7% compared to the prior year [15] - Adjusted earnings per share for Q3 2025 were $0.37, at the midpoint of quarterly guidance [4] - GAAP net income for Q3 2025 was $2.5 million, or diluted earnings per share of $0.09, down from $8.6 million or $0.31 in the same quarter last year [19] - Adjusted EBITDA was $15.3 million, or 21.2% of revenues before reimbursements, compared to 22.7% in the prior year [19] Business Line Data and Key Metrics Changes - Global GS&BT segment revenues were $42.4 million, a decrease of 2% year-over-year, but would have increased by 4% excluding the OneStream practice and iPaaS contract [15][16] - Oracle Solutions segment revenues were $16.4 million, down 25% year-over-year due to prolonged decision-making [16] - SAP Solutions segment revenues were $13.4 million, an increase of 4% year-over-year, driven by implementation services [16] Market Data and Key Metrics Changes - Approximately 23% of total revenues before reimbursements consist of recurring multi-year and subscription-based revenues [17] - Days Sales Outstanding (DSO) improved to 71 days from 73 days in the previous quarter [21] Company Strategy and Development Direction - The company is focusing on GenAI-enabled transformation, which is seen as a generational opportunity to change operational and consulting service delivery [27][28] - The recent launch of version 4 of the AI Explorer platform is expected to enhance client engagement and pipeline activity [4][39] - Strategic alliances are being pursued to expand growth opportunities, with ongoing discussions with potential partners [34][35] Management's Comments on Operating Environment and Future Outlook - The demand for digital transformation remains strong but is impacted by economic concerns and decision-making delays [27] - The company expects continued growth in GenAI revenues, particularly in Q4 and into 2026 [16][39] - Management anticipates a decrease in available billing days in Q4 due to holiday schedules, estimating revenues before reimbursements to be in the range of $69.5-$71 million [23] Other Important Information - The company announced a $40 million Dutch tender offer to repurchase approximately 8% of its common stock [11][22] - Cash balances increased to $13.9 million at the end of Q3, up from $10.1 million in the previous quarter [21] Q&A Session Summary Question: Plans for alliances and partnerships - Management expressed confidence in attracting major alliance partners due to the capabilities demonstrated by version 4 of AI Explorer [34][35] Question: Licensing progress for ZBrain and Explorer - Licensing for version 4 is expected to begin late in Q4 or early Q1, with anticipated interest from current clients [41][42] Question: Trends within GS&BT segment - The strategy and business transformation group represents a significant portion of GS&BT revenues, with expectations for GenAI initiatives to drive future profits [43][44] Question: Decision-making trends among clients - Management noted that while clients are cautious about 2025 spending, there is an increasing willingness to invest in digital transformation initiatives [46] Question: Labor resources to meet AI demand - Management indicated that productivity improvements from new platforms will reduce reliance on headcount growth [47]
The Hackett Group(HCKT) - 2025 Q3 - Earnings Call Transcript